2022-12-01 2023-11-30 false Capium Accounts Production 1.1 12338180 bus:FullAccounts 2022-12-01 2023-11-30 12338180 bus:FRS102 2022-12-01 2023-11-30 12338180 bus:AuditExemptWithAccountantsReport 2022-12-01 2023-11-30 12338180 bus:SmallCompaniesRegimeForAccounts 2022-12-01 2023-11-30 12338180 bus:PrivateLimitedCompanyLtd 2022-12-01 2023-11-30 12338180 2022-12-01 2023-11-30 12338180 2023-11-30 12338180 bus:RegisteredOffice 2022-12-01 2023-11-30 12338180 core:WithinOneYear 2023-11-30 12338180 core:AfterOneYear 2023-11-30 12338180 bus:Director1 2022-12-01 2023-11-30 12338180 bus:Director1 2023-11-30 12338180 bus:Director1 2021-12-01 2022-11-30 12338180 2021-12-01 12338180 bus:CompanySecretary1 2022-12-01 2023-11-30 12338180 bus:LeadAgentIfApplicable 2022-12-01 2023-11-30 12338180 2021-12-01 2022-11-30 12338180 2022-11-30 12338180 core:WithinOneYear 2022-11-30 12338180 core:AfterOneYear 2022-11-30 12338180 bus:EntityAccountantsOrAuditors 2021-12-01 2022-11-30 12338180 core:ComputerEquipment 2022-12-01 2023-11-30 12338180 core:ComputerEquipment 2023-11-30 12338180 core:ComputerEquipment 2022-11-30 12338180 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2023-11-30 12338180 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2022-11-30 12338180 core:NetGoodwill 2022-12-01 2023-11-30 12338180 core:CostValuation core:Non-currentFinancialInstruments 2023-11-30 12338180 core:CostValuation core:Non-currentFinancialInstruments 2022-11-30 12338180 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2023-11-30 12338180 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2023-11-30 12338180 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2023-11-30 12338180 core:Non-currentFinancialInstruments 2023-11-30 12338180 core:Non-currentFinancialInstruments 2022-11-30 12338180 core:ShareCapital 2023-11-30 12338180 core:ShareCapital 2022-11-30 12338180 core:RetainedEarningsAccumulatedLosses 2023-11-30 12338180 core:RetainedEarningsAccumulatedLosses 2022-11-30 12338180 dpl:Item1 2022-12-01 12338180 dpl:Item1 2023-11-30 12338180 dpl:Item1 2021-12-01 12338180 dpl:Item1 2022-11-30 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 12338180
England and Wales

 

 

 

EJA MEDICAL LTD


Unaudited Financial Statements
 


Period of accounts

Start date: 01 December 2022

End date: 30 November 2023
Director Mouri ISLAM
Registered Number 12338180
Registered Office 93 Goresbrook Road
Dagenham
RM9 6YG
Accountants ASR Accountancy Ltd
18 Barking Road
East Ham
London
E6 3BP
1
Accountant’s report
You consider that the company is exempt from an audit for the year ended 30 November 2023 . You have acknowledged, on the balance sheet, your responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These responsibilities include preparing accounts that give a true and fair view of the state of affairs of the company at the end of the financial year and of its profit or loss for the financial year.
In accordance with your instructions, we have prepared the accounts which comprise the Profit and Loss Account, the Statement of Comprehensive Income, the Balance Sheet, the Statement of Changes in Equity and the related notes from the accounting records of the company and on the basis of information and explanations you have given to us.
We have not carried out an audit or any other review, and consequently we do not express any opinion on these accounts.
ASR Accountancy Ltd
30 November 2023



....................................................
ASR Accountancy Ltd
18 Barking Road
East Ham
London
E6 3BP
02 April 2024
2
 
 
Notes
 
2023
£
  2022
£
Fixed assets      
Tangible fixed assets 3 1    267 
1    267 
Current assets      
Debtors 4 27,966    25,625 
Cash at bank and in hand 12,894    9,523 
40,860    35,148 
Creditors: amount falling due within one year 5 (15,739)   (16,570)
Net current assets 25,121    18,578 
 
Total assets less current liabilities 25,122    18,845 
Creditors: amount falling due after more than one year 6 (18,151)  
Net assets 6,971    18,845 
 

Capital and reserves
     
Called up share capital 2    2 
Profit and loss account 6,969    18,843 
Shareholder's funds 6,971    18,845 
 


For the year ended 30 November 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.
The financial statements were approved by the director on 02 April 2024 and were signed by:


-------------------------------
Mouri ISLAM
Director
3
General Information
Eja Medical Ltd is a private company, limited by shares, registered in England and Wales, registration number 12338180, registration address 93 Goresbrook Road, Dagenham, RM9 6YG.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared on the going concern basis and under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
Government grants
Government grants received are credited to deferred income. Grants towards capital expenditure are released to the income statement over the expected useful life of the assets. Grants received towards revenue expenditure are released to the income statement as the related expenditure is incurred.
Operating lease rentals
Rentals payable under operating leases are charged against income on a straight line basis over the lease term.
Research and development expenditure
Research and development expenditure is charged to the income statement in the period in which it is incurred.
Website cost
Planning and operating costs for the company's website are charged to the income statement as incurred.
Taxation
Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves.
The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Current and deferred tax assets and liabilities are not discounted
Dividends
Proposed dividends are only included as liabilities in the statement of financial position when their payment has been approved by the shareholders prior to the statement of financial position date.
Goodwill
Acquired goodwill is stated at cost less amortisation. Amortisation is calculated on a straight line basis over the estimated expected useful economic life of the goodwill of years.
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost less depreciation. Depreciation is provided at rates calculated to write off the cost of fixed assets over their expected useful lives on the following basis:
Computer Equipment 3 Straight Line
2.

Average number of employees

Average number of employees during the year was 1 (2022 : 1).
3.

Tangible fixed assets

Cost or valuation Computer Equipment   Total
  £   £
At 01 December 2022 799    799 
Additions  
Disposals  
At 30 November 2023 799    799 
Depreciation
At 01 December 2022 532    532 
Charge for year 266    266 
On disposals  
At 30 November 2023 798    798 
Net book values
Closing balance as at 30 November 2023 1    1 
Opening balance as at 01 December 2022 267    267 


4.

Debtors: amounts falling due within one year

2023
£
  2022
£
Trade Debtors   5,625 
Other Debtors 20,000    20,000 
20,000    25,625 

4.

Debtors: amounts falling due after one year

2023
£
  2022
£
Directors Loan Accounts 7,966   
7,966   

5.

Creditors: amount falling due within one year

2023
£
  2022
£
Corporation Tax 15,401    14,626 
PAYE & Social Security   856 
Other Creditors   750 
Directors' Current Accounts 338    338 
15,739    16,570 

6.

Creditors: amount falling due after more than one year

2023
£
  2022
£
Hire Purchase 18,151   
18,151   

4